Quarterly report [Sections 13 or 15(d)]

Basis of Presentation and Nature of Operations (Details Narrative)

v3.25.3
Basis of Presentation and Nature of Operations (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Jul. 02, 2025
Jun. 03, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Accounting Policies [Abstract]                      
Stockholders' equity, reverse stock split   1-for-30                  
Net loss     $ 3,066,589 $ 2,272,035 $ 2,216,993 $ 2,462,870 $ 2,305,090 $ 2,450,833 $ 7,555,617 $ 7,218,795  
Operating activities                 6,410,975 $ 6,579,029  
Accumulated deficit     224,341,789           224,341,789   $ 216,786,172
Cash and cash equivalents     $ 11,400,000           11,400,000    
Net proceeds from private placements and sales of common stock                 2,600,000    
Proceeds from issuance of preferred stock and warrants $ 15,200,000               15,200,000    
Proceeds from issuance of debt, net of issuance costs                 $ 2,200,000